Arcutis Biotherapeutics Inc【ARQT】株式ニュース | ADVFN

US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Arcutis Biotherapeutics Inc (ARQT)
Arcutis Biotherapeutics Inc (ARQT) ニュース

Arcutis Biotherapeutics Inc (ARQT)

16.60

0.73

(4.60%)

終了 3月20日 5:00AM

16.90

0.30

(1.81%)

取引時間後: 7:59AM

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

Arcutis to Highlight Data from Phase 3 Trials for Scalp and Body Psoriasis and Atopic Dermatitis at the 83rd American Academy of Dermatology Meeting

Data demonstrated favorable safety and local tolerability of ZORYVE® (roflumilast) cream 0.15% in adults and...

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WESTLAKE VILLAGE, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Arcutis to Present Two Posters at the 83rd American Academy of Dermatology Annual Meeting

One poster will share pooled INTEGUMENT data of ZORYVE® (roflumilast) cream 0.15% in atopic dermatitis (AD) in...

U.S. FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Children Aged 2 to 5 with Mild to Moderate Atopic Dermatitis

U.S. Food and Drug Administration (FDA) has set a Prescription Drug User Fee Act (PDUFA) target action date of...

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

52172

Keep marching 20's imminent

Monksdream

Monksdream 6月前

52172

Ath’s incoming

52172

Put the crackpipe down

52172

Wrong we beat big time sucka

52172

Sierra20

Sierra20 7月前

Sierra20

Sierra20 7月前

Earnings missed big time and this tanks hard

52172

Not yet need 20’s which will come

MiamiGent

MiamiGent 8月前

ARQT $10.82 HOD!
Everybody happy?

52172

Some large transactions happening a sign of whats to come

52172

Gonna close green watch

MiamiGent

MiamiGent 8月前

ARQT The short interest is about 25%
The free trading float is tiny.
Share Price should rise steadily today.

MiamiGent

MiamiGent 8月前

ARQT $10.69 last pre-mkt buy, up .67 from yesterday's close.
Steadily rising, as I expected.

The mkt for this FDA approved medicine (last night) is reportedly multi- billions of dollars.

52172

MiamiGent

MiamiGent 8月前

ARQT Needham Reiterates BUY on Arcutis Biotherapeutics, maintains $18 Price Target

6:28 AM this morning

MiamiGent

MiamiGent 8月前

ARQT That's right. The market for this is reportedly three times larger than the previous approved candidate- and that one grew about 250% last qtr.
AND, Arcutis (ARQT) will roll out this new medicine by the end of THIS MONTH.

I am going to buy this product- I have psoriasis all over, except my face thank God.

52172

Real revenue is gonna begin to come in.

52172

Headed to 20’s soon enough!

MiamiGent

MiamiGent 8月前

$ARQT HUge short interest, next to no free float and FDA Approval tonight for a BIG MARKET drug.
The boys will run this tomorrow.

MiamiGent

MiamiGent 8月前

$ARQT
Arcutis Biotherapeutics Inc

My guess it'll be $11 by 8PM.
The real fun starts in Pre-Market, tomorrow, And then I think off to the races in Regular Session.
Bullish

MiamiGent

MiamiGent 8月前

$ARQT Tight Bid and ASK now.
Getting serious.
Bid ARCX
10.55 x 10
Ask XNMS
10.59 x 1
Volume
2,437,578
Bullish

MiamiGent

MiamiGent 8月前

$ARQT
Arcutis Biotherapeutics Inc

I told ya!
Currently in AH
Bid XNMS 10.50 x 13
Ask ARCX 10.67 x 20
Volume
2,429,849
Bullish

MiamiGent

MiamiGent 8月前

$ARQT New traders: Look at those big $10.48 buys!
The few that follow are "paint jobs"- shorts trying to paint weakness.
Pay attention to the big buys!
$ARQT
18:07:49 $10.41 5 paint job
18:07:49 $10.35 20 paint job
18:07:45 $10.48 15 paint job
18:07:25 $10.48 7,900 real buy
18:07:25 $10.48 1,500 real buy
18:07:01 $10.3567 30
18:05:44 $10.49 115
18:04:57 $10.49 9,400
18:04:26 $10.4887 110
18:03:38 $10.42 6,212
18:03:38 $10.42 2,200
Bullish

MiamiGent

MiamiGent 8月前

ARQT Arcutis Biotherapeutics' Zoryve Gets US FDA Approval!

Sierra20

Sierra20 8月前

I hope it will be approved. I think it will be approved. It’s just weird.

MiamiGent

MiamiGent 8月前

You're being unnecessarily doomsdayish, Sierra.

Fact is FDA has not announced re any candidates since July 3rd. There's an American holiday on the 4th (Thursday) and folks often take the next day off to make it a four-day break with only one vacation day used.
Hope the weather is not as hot in Albania or wherever it is you plot your short plays and bashing.
MG

Sierra20

Sierra20 8月前

CRL more than likely. I knew it. F! This is horrible!!!!
https://investors.arcutis.com/news-releases/news-release-details/arcutis-provides-update-snda-roflumilast-cream-015-atopic/

Sierra20

Sierra20 8月前

They got CRL. 😔
There’s no other reason for this delay. Back to $5 I think.

Sierra20

Sierra20 8月前

I think they are talking to fda to figure out what they needed to do to address the fda’s concerns before giving a pr about CRL.

MiamiGent

MiamiGent 8月前

ARQT Only 40 more minutes for FDA to announce today.
One time it did at 11:30 PM and it was a QUADRUPLE!

MiamiGent

MiamiGent 8月前

You must be short. There's no basis for what you are saying.

MiamiGent

MiamiGent 8月前

AQRT I'm in today.

Sierra20

Sierra20 8月前

CRL coming at 4 pm est. imo.

Sierra20

Sierra20 8月前

I think CRL coming…

Sierra20

Sierra20 8月前

52172

Havent missed nothing yet!

52172

Sierra20

Sierra20 8月前

I have the worst luck. I miss all the PDUFA. If they get delayed should not be a problem.

Sierra20

Sierra20 8月前

Sierra20

Sierra20 8月前

CRL? Delayed? What’s going on?

Monksdream

Monksdream 8月前

52172

No one knows shit approval is imminent

Sierra20

Sierra20 9月前

Someone knows something sell off started. 😔

Sierra20

Sierra20 9月前

I hope they didn’t get a CRL. People are selling. Something is going on.

52172

408k share buy ah’s nothing else needed to say!

52172

20’s imminent mark this post

52172

Load the boat easy money

52172

52172

ER coming on the 14th might get a bump then data in july

Arcutis Biotherapeutics

Tahera Diamond (CE)

RSE Collection (GM)

Vontobel Financial Produ...

Laurentian Bank of Canada

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約